Mostly Markets
Subscribe
Stocks/Health Care/Health Care Services

Quest DiagnosticsDGX

Health Care Services · Secaucus, New Jersey · In the S&P 500
Solid business
$251.82−0.43%After hours: $251.82 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 44.1% over 1 year
Quest Diagnostics over 1 yearDaily close, $, to 30 Oct 2026
$175$200$225Nov2026MarMayJulSep$251.82$200NovMarJul$251.82
Source: Nasdaq daily closes
Market value$27.70B
Price to earnings25.1x
Forward P/E22.2x
Dividend yield1.37%
Year to date+45.1%
One year+44.1%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$173.49$252.92

Quality and valuation

How Quest Diagnostics compares with other health care stocks. A description, not a recommendation.

Quest Diagnostics and 5 health care services peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: in line with its sector

An average business among health care companies, priced about in line with them.

Quest Diagnostics trades at 22.2 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +9.1% vs +7.8%
  • Keeps less of each sale (gross margin): 33.1% vs 65.3%
  • More profitable (operating margin): 14.6% vs 13.3%
  • Turns less of its sales into cash: 11.6% vs 15.9%
DGX trades at 22.2x forward earnings, above the sector medianForward p/e, Health Care Services peers
CI9.4xCVS11.1xDVA11.9xLH19.1xDGX22.2xHIMS73.4xSector median 19.1xCI9.4xCVS11.1xDVA11.9xLH19.1xDGX22.2xHIMS73.4xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 25.1x earnings, DGX is pricier than its average since Oct 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
20x22x24x26xAverage 22.3x2025202625.1x20x22xAverage 22.3x2025202625.1x
Source: Nasdaq prices; SEC filings

Financials

From Quest Diagnostics's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.

Revenue grew 10.0% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0bn$1bn$2bn$3bnQ4 ’24Q2 ’25Q4 ’25$3.1bnQ3 ’26$0bn$2bnQ4 ’24Q2 ’25Q4 ’25$3.1bnQ3 ’26
Source: SEC filings
Growth slowed to +10.0% last quarterRevenue growth, year on year, %
0%5%10%15%Q4 ’24Q2 ’25Q4 ’2510.0%Q3 ’260%10%Q4 ’24Q2 ’25Q4 ’2510.0%Q3 ’26
Source: SEC filings
Operating margin was 15.5% last quarterOperating income as a share of revenue, %
0%5%10%15%Q4 ’24Q2 ’25Q4 ’2515.5%Q3 ’260%10%Q4 ’24Q2 ’25Q4 ’2515.5%Q3 ’26
Source: SEC filings
Free cash flow was $1.4 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
$0m$200m$400mQ4 ’24Q2 ’25Q4 ’25$445mQ3 ’26$0m$200m$400mQ4 ’24Q2 ’25Q4 ’25$445mQ3 ’26
Source: SEC filings
Last 12 monthsDGXSector median
Revenue growth+9.1%+7.8%
Gross margin33.1%65.3%
Operating margin14.6%13.3%
Free cash flow margin11.6%15.9%
Price to earnings25.1x30.2x

Stories on Quest Diagnostics

We haven't written about Quest Diagnostics yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Services, by market value.

CompanyPriceTodayYTDValue
CVSCVS Health$90.25−0.09%+13.7%$115B
CICigna$298.23−0.06%+8.4%$78.80B
LHLabcorp$361.39−1.84%+44.0%$29.34B
DVADaVita$187.50−3.01%+65.0%$11.96B
HIMSHims & Hers Health$27.68−6.71%−14.8%$6.46B